ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel

June 1, 2001

Lung, Head & Neck Treatment Advances Reported At ASCO Annual Meeting

May 27, 1977

With $10.4 Billion To Spend In 18 Months, NIH Says Money Will Be Spent Rationally. Funds Will Support R01s

February 20, 2009

Funding opportunties listed.

December 3, 2004

House Passes Bill Giving FDA Authority Over Tobacco Products

April 10, 2009

Institutinal Training Awards Hardest Hit As New Budget Cuts Will Slash Into Noncompeting Grants

March 13, 1981